In the last trading session, 16.4 million shares of the 180 Life Sciences Corp (NASDAQ:ATNF) were traded, and its beta was 0.35. Most recently the company’s share price was $3.0, and it changed around $0.87 or 40.85% from the last close, which brings the market valuation of the company to $18.12M. ATNF currently trades at a discount to its 52-week high of $17.75, offering almost -491.67% off that amount. The share price’s 52-week low was $0.66, which indicates that the current value has risen by an impressive 78.0% since then. We note from 180 Life Sciences Corp’s average daily trading volume that its 10-day average is 11.47 million shares, with the 3-month average coming to 1.69 million.
180 Life Sciences Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ATNF as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
180 Life Sciences Corp (NASDAQ:ATNF) trade information
Instantly ATNF has showed a green trend with a performance of 40.85% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.48 on recent trading dayincreased the stock’s daily price by 13.79%. The company’s shares are currently up 31.58% year-to-date, but still up 59.57% over the last five days. On the other hand, 180 Life Sciences Corp (NASDAQ:ATNF) is 240.99% up in the 30-day period. We can see from the shorts that 63946.0 shares have been sold at a short interest cover period of 0.81 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 55.37%.
ATNF Dividends
180 Life Sciences Corp’s next quarterly earnings report is expected to be released on 2022-Nov-10.
180 Life Sciences Corp (NASDAQ:ATNF)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 62.83% of 180 Life Sciences Corp shares, and 1.36% of them are in the hands of institutional investors. The stock currently has a share float of 3.66%.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Apr 30, 2025 . The former held 12.1 shares worth $36312.0, making up 0.20% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 2.83 shares worth around $8487.0, which represents about 0.05% of the total shares outstanding.
